Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/24/2022 | Press release | Distributed by Public on 01/24/2022 00:11
Please select the service you want to use:
Smartlinks | Epigenomics AG | News | Health | Biotechnology | Technology | Biotechnology | Science | Biotechnology | Research | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Company Appointments | Corporate Officer Change | Products and Services | Corporate Litigation and Regulation | Manufacturing | Pharmaceuticals | Recreational and Sporting Goods | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | OTC Markets | BX Swiss | Tradegate Exchange | XETRA | Turquoise | Börse Hamburg | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Euronext Block MTF
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact